Supernus Pharmaceuticals | SUPN - Market Capitalization


Supernus Pharmaceuticals reported $2.45B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
ANI Pharmaceuticals USD 1.75B 24M Mar/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Corcept Therapeutics USD 4.32B 654M Mar/2026
Eisai JPY 1.42T 110.62B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026